Related Experiment Video
Updated: May 13, 2026

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
Published on: January 16, 2026
Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression
1Department of Oral Medicine, Dental Clinic of Xuhui District, 685 Zhaojiabang Road, Shanghai 200032, People's Republic of China.
Abstract:
Long noncoding RNAs (lncRNAs) are key regulators of diverse biological processes such as transcriptional regulation, cell growth and differentiation. Previous studies have demonstrated that the lncRNA-ANCR (anti-differentiation ncRNA) is required to maintain the undifferentiated cell state within the epidermis. However, little is known about whether ANCR regulates osteoblast differentiation. In this study, we found that the ANCR expression level is significantly decreased during hFOB1.19 cell differentiation. ANCR-siRNA blocks the expression of endogenous ANCR, resulting in osteoblast differentiation, whereas ANCR overexpression is sufficient to inhibit osteoblast differentiation. We further demonstrated that ANCR is associated with enhancer of zeste homolog 2 (EZH2) and that this association results in the inhibition of both Runx2 expression and subsequent osteoblast differentiation. These data suggest that ANCR is an essential mediator of osteoblast differentiation, thus offering a new target for the development of therapeutic agents to treat bone diseases.
Insights
Long noncoding RNA ANCR (anti-differentiation ncRNA) inhibits osteoblast differentiation by interacting with EZH2. Decreased ANCR levels promote bone cell differentiation, suggesting ANCR as a therapeutic target for bone diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) regulate crucial biological processes, including cell differentiation.
- The lncRNA-ANCR (anti-differentiation ncRNA) is known to maintain undifferentiated states in the epidermis.
- The role of ANCR in osteoblast differentiation remains largely unexplored.
Purpose of the Study:
- To investigate the role of ANCR in regulating osteoblast differentiation.
- To elucidate the molecular mechanisms by which ANCR influences bone cell development.
Main Methods:
- Quantitative analysis of ANCR expression during osteoblast differentiation.
- Manipulation of ANCR levels using siRNA and overexpression techniques.
- Co-immunoprecipitation assays to assess ANCR-EZH2 interaction.
- Analysis of Runx2 expression levels.
Main Results:
- ANCR expression significantly decreases during human osteoblast (hFOB1.19) differentiation.
- ANCR knockdown promotes osteoblast differentiation, while ANCR overexpression inhibits it.
- ANCR physically associates with enhancer of zeste homolog 2 (EZH2).
- ANCR-EZH2 complex formation inhibits Runx2 expression, a key factor in osteoblast differentiation.
Conclusions:
- ANCR acts as a critical negative regulator of osteoblast differentiation.
- The ANCR-EZH2 interaction is essential for suppressing osteoblastogenesis.
- ANCR represents a potential therapeutic target for managing bone diseases and promoting bone regeneration.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Master Transcription Regulators
Co-activators and Co-repressors
Osteoclasts in Bone Remodeling